|
(V1284) |
Endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice |
| |
|
M. Bochenek, T. Bauer, R. K. Gogiraju, T. Münzel, P. Wenzel, S. Konstantinides, K. Schäfer (Mainz) |
|
|
Diskussion |
|
(V1285) |
The Chemokine Receptor CXCR7 on Platelets can be utilised as an Anti-Thrombotic Therapeutic Target |
| |
|
M. Chatterjee, A. Witte, M. Büttcher, J. Sudmann, D. Rath, N. Ferreirós Bouzas, M. Gawaz (Tübingen, Frankfurt am Main) |
|
|
Diskussion |
|
(V1286) |
Enhancement of platelet reactivity by ACE inhibitors can be blunted by switching to angiotensin II receptor antagonists |
| |
|
C. Helten, A. Achilles, L. K. Dannenberg, P. Mourikis, D. Naguib, M. Pöhl, R. M'Pembele, A. Ayhan, B. Knoop, S. Zako, T. Hohlfeld, M. Kelm, T. Zeus, A. Polzin (Düsseldorf) |
|
|
Diskussion |
|
(V1287) |
A novel role for S100A1 in primary hemostasis: impact on platelet glycoprotein 6 expression and platelet function in arterial thrombosis |
| |
|
N. Gade, Y. Boulaftali, H. A. Katus, W. Bergmeier, M. Busch, P. Most (Heidelberg; Paris Cedex 18, FR; Chapel Hill, US) |
|
|
Diskussion |
|
(V1288) |
Activation of integrin αIIbβ3 is reduced by specific inhibition of MRP4/ABCC4 in human platelets |
| |
|
R. Wolf, S. Grammbauer, A. Böhm, G. Jedlitschky, B. H. Rauch (Greifswald) |
|
|
Diskussion |
|
(V1289) |
Endothelial cell-specific expression of Angiopoietin-2 (Angpt-2) impairs venous thrombus resolution |
| |
|
L. Hobohm, Y. Reiss, S. Kölmel, T. Münzel, S. Konstantinides, K.-H. Plate, P. Wenzel, K. Schäfer, M. K. Lankeit (Mainz, Frankfurt/Main, Berlin) |
|
|
Diskussion |